Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 2
Submit an article Journal homepage
325
Views
12
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results

Wanqiu YangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China,
,
Qingqing XiaoDepartment of Clinical Pharmacy, School of Pharmacy, China Pharmaceutical University, Nanjing, China, and
,
Dan WangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China,
,
Cheng YaoNanjing Frontier Biotechnologies Co, Nanjing, China
&
Jin YangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China, Correspondence[email protected]
Pages 133-143 | Received 09 Jan 2016, Accepted 13 Mar 2016, Published online: 06 Apr 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrea Calcagno, Mattia Trunfio, Antonio D’Avolio, Giovanni Di Perri & Stefano Bonora. (2021) The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV. Expert Opinion on Drug Metabolism & Toxicology 17:6, pages 665-676.
Read now
Maddalena Cerrone, Margherita Bracchi, Sean Wasserman, Anton Pozniak, Graeme Meintjes, Karen Cohen & Robert J Wilkinson. (2020) Safety implications of combined antiretroviral and anti-tuberculosis drugs. Expert Opinion on Drug Safety 19:1, pages 23-41.
Read now

Articles from other publishers (10)

Huanxia LiuShenghua He, Tongtong YangChunrong LuYuan YaoRuifeng ZhouKe YinYuanhong HeJing Cheng. (2023) Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS. Medicine 102:45, pages e35344.
Crossref
Huiling Qin, Cheng Yao, Wei Zhang, Wei Hu, Yuantao Liu, Shuchang Yu, Dong Xie, Min Hu & Jun Ye. (2023) Comparison of pharmacokinetics and safety of albuvirtide in healthy subjects after intravenous drip and bolus injection. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Yvonne M. Angell, Wendy J. Hartsock & Timothy M. Reichart. 2022. Current Drug Synthesis. Current Drug Synthesis 101 118 .
Bin Su, Cheng Yao, Qing-Xia Zhao, Wei-Ping Cai, Min Wang, Hong-Zhou Lu, Yuan-Yuan Chen, Li Liu, Hui Wang, Yun He, Yu-Huang Zheng, Ling-Hua Li, Jin-Feng Chen, Jian-Hua Yu, Biao Zhu, Min Zhao, Yong-Tao Sun, Wen-Hui Lun, Wei Xia, Li-Jun Sun, Li-Li Dai, Tai-Yi Jiang, Mei-Xia Wang, Qing-Shan Zheng, Hai-Yan Peng, Yao Wang, Rong-Jian Lu, Jian-Hua Hu, Hui XingYi-Ming ShaoDong Xie, Tong Zhang, Fu-Jie Zhang & Hao Wu. (2020) Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study. Chinese Medical Journal 133:24, pages 2919-2927.
Crossref
Aarzoo Thakur, Shawn Pei Feng Tan & James Chun Yip Chan. (2020) Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2. Clinical Pharmacology & Therapeutics 108:6, pages 1176-1184.
Crossref
Minhua Peng. (2020) Outbreak of COVID-19: An emerging global pandemic threat. Biomedicine & Pharmacotherapy 129, pages 110499.
Crossref
Y. Li, S.-F. Chen, X.-J. Dong & X.-J. Zhao. (2020) Prediction of cause-specific disability-adjusted life years in China from 2018 through 2021: a systematic analysis. Public Health 180, pages 90-99.
Crossref
Xiaoli Du, Wenxiu Peng, Qiang Fu, Qing Ma, Zhu Zhu & Taisheng Li. (2019) A Review of Clinical Pharmacokinetic and Pharmacodynamic Profiles of Select Antiretrovirals: Focus on Differences among Chinese Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:12, pages 1179-1189.
Crossref
Lulu Zuo, Ke Peng, Yihong Hu & Qinggang Xu. (2019) Genotypic Methods for HIV Drug Resistance Monitoring: The Opportunities and Challenges Faced by China. Current HIV Research 17:4, pages 225-239.
Crossref
Emmanuele Venanzi Rullo, Manuela Ceccarelli, Fabrizio Condorelli, Alessio Facciol�, Giuseppa Visalli, Francesco D'Aleo, Ivana Paolucci, Bruno Cacopardo, Marilia Pinzone, Michele Di Rosa, Giuseppe Nunnari & Giovanni Pellican�. (2019) Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.